Cargando…
A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
BACKGROUND: The content validity (appropriateness and acceptability) of patient‐reported outcome (PRO) measures for scalp hair loss, eyebrow loss, eyelash loss, nail damage and eye irritation has been demonstrated in adults with alopecia areata (AA) but not adolescents. OBJECTIVES: To explore the co...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305453/ https://www.ncbi.nlm.nih.gov/pubmed/34811721 http://dx.doi.org/10.1111/bjd.20904 |
_version_ | 1784752329019359232 |
---|---|
author | Macey, Jake Kitchen, Helen Aldhouse, Natalie V.J. Edson‐Heredia, Emily Burge, Russel Prakash, Apurva King, Brett A. Mesinkovska, Natasha |
author_facet | Macey, Jake Kitchen, Helen Aldhouse, Natalie V.J. Edson‐Heredia, Emily Burge, Russel Prakash, Apurva King, Brett A. Mesinkovska, Natasha |
author_sort | Macey, Jake |
collection | PubMed |
description | BACKGROUND: The content validity (appropriateness and acceptability) of patient‐reported outcome (PRO) measures for scalp hair loss, eyebrow loss, eyelash loss, nail damage and eye irritation has been demonstrated in adults with alopecia areata (AA) but not adolescents. OBJECTIVES: To explore the content validity of the suite of AA PRO measures and accompanying photoguides in an adolescent sample. METHODS: Semi‐structured, 90‐min, combined concept elicitation and cognitive interviews were conducted face‐to‐face with adolescents who experienced ≥ 50% AA‐related scalp hair loss. Transcripts underwent thematic and framework analysis. RESULTS: Eleven adolescents (aged 12–17 years, 55% female, 45% nonwhite) diagnosed with AA for 5·9 years (mean) participated. Participants had 69·6% scalp hair (mean) and current eyebrow (82%) and/or eyelash loss (82%) and/or nail involvement (36%). Adolescents reported scalp, eyebrow and eyelash hair loss as their top three most bothersome signs/symptoms. Despite mostly accepting their AA, impacts related to visible areas of hair loss were prominent. Participants demonstrated good understanding and appropriate use of the PRO measures, and advocated including hair loss percentages alongside descriptive categories in the Scalp Hair Assessment PRO™. Results confirmed treatment success thresholds established with adults: achievement of ≤ 20% scalp hair loss, no/minimal eyebrow and eyelash loss, no/a little nail damage and eye irritation (PRO measure categories 0 or 1). CONCLUSIONS: The Scalp Hair Assessment PRO™, PRO Measure for Eyebrows™, PRO Measure for Eyelashes™, PRO Measure for Nail Appearance™ and PRO Measure for Eye Irritation™ and accompanying photoguides are fit‐for‐purpose self‐reported measures of AA signs/symptoms that are impactful to adolescents with AA. |
format | Online Article Text |
id | pubmed-9305453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93054532022-07-28 A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures Macey, Jake Kitchen, Helen Aldhouse, Natalie V.J. Edson‐Heredia, Emily Burge, Russel Prakash, Apurva King, Brett A. Mesinkovska, Natasha Br J Dermatol Original Articles BACKGROUND: The content validity (appropriateness and acceptability) of patient‐reported outcome (PRO) measures for scalp hair loss, eyebrow loss, eyelash loss, nail damage and eye irritation has been demonstrated in adults with alopecia areata (AA) but not adolescents. OBJECTIVES: To explore the content validity of the suite of AA PRO measures and accompanying photoguides in an adolescent sample. METHODS: Semi‐structured, 90‐min, combined concept elicitation and cognitive interviews were conducted face‐to‐face with adolescents who experienced ≥ 50% AA‐related scalp hair loss. Transcripts underwent thematic and framework analysis. RESULTS: Eleven adolescents (aged 12–17 years, 55% female, 45% nonwhite) diagnosed with AA for 5·9 years (mean) participated. Participants had 69·6% scalp hair (mean) and current eyebrow (82%) and/or eyelash loss (82%) and/or nail involvement (36%). Adolescents reported scalp, eyebrow and eyelash hair loss as their top three most bothersome signs/symptoms. Despite mostly accepting their AA, impacts related to visible areas of hair loss were prominent. Participants demonstrated good understanding and appropriate use of the PRO measures, and advocated including hair loss percentages alongside descriptive categories in the Scalp Hair Assessment PRO™. Results confirmed treatment success thresholds established with adults: achievement of ≤ 20% scalp hair loss, no/minimal eyebrow and eyelash loss, no/a little nail damage and eye irritation (PRO measure categories 0 or 1). CONCLUSIONS: The Scalp Hair Assessment PRO™, PRO Measure for Eyebrows™, PRO Measure for Eyelashes™, PRO Measure for Nail Appearance™ and PRO Measure for Eye Irritation™ and accompanying photoguides are fit‐for‐purpose self‐reported measures of AA signs/symptoms that are impactful to adolescents with AA. John Wiley and Sons Inc. 2022-02-25 2022-05 /pmc/articles/PMC9305453/ /pubmed/34811721 http://dx.doi.org/10.1111/bjd.20904 Text en © 2022 Eli Lilly and Company. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Macey, Jake Kitchen, Helen Aldhouse, Natalie V.J. Edson‐Heredia, Emily Burge, Russel Prakash, Apurva King, Brett A. Mesinkovska, Natasha A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures |
title | A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
|
title_full | A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
|
title_fullStr | A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
|
title_full_unstemmed | A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
|
title_short | A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
|
title_sort | qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305453/ https://www.ncbi.nlm.nih.gov/pubmed/34811721 http://dx.doi.org/10.1111/bjd.20904 |
work_keys_str_mv | AT maceyjake aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT kitchenhelen aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT aldhousenatalievj aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT edsonherediaemily aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT burgerussel aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT prakashapurva aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT kingbretta aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT mesinkovskanatasha aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT maceyjake qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT kitchenhelen qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT aldhousenatalievj qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT edsonherediaemily qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT burgerussel qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT prakashapurva qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT kingbretta qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures AT mesinkovskanatasha qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures |